Your Global Leader in Stem Cell Market Research
Are you or a loved on suffering from arthritis, multiple sclerosis (MS), COPD, Alzheimer’s disease, asthma, or other chronic condition? If so, how do you find a stem cell clinical trial?
This article provides the answers, including links to find a clinical trials near you, as well as links to clinical trials for specific conditions.
The history of cord blood banking is fascinating, because the service did not exist on a wide-spread basis until a few decades ago. Below, we introduce key historical events that have affected cord blood and cord tissue storage and how they could impact you, your family, or your investment portfolio.
[Read more…]
The global cord blood industry came into existence in the early 1990’s with the formation of several leading cord blood banks in the USA, followed by the establishment of cord blood banks across the globe. However, the history of cord blood stem cell transplantation begins much earlier than that. [Read more…]
This article is a comparison of the top 3 largest cord blood banks in the United States.
In this article:
The top three U.S. cord blood banks by the number of units stored are:
The standard used to identify these cord blood banks was the number of umbilical cord blood and tissue units stored by each company.
The purpose of this analysis is to compare pricing and banking services among the largest cord blood banks within the U.S., the most mature cord blood banking market in the world.
These three industry giants also represent several of the largest cord blood banks worldwide.
The three cord blood bank companies considered in this analysis are Cord Blood Registry, ViaCord, and Cryo-Cell. These three companies are not only the three market leaders in the United States by the number of cord blood and tissue units banked but are also some of the largest cord blood banks worldwide.
The Cord Blood Registry or CBR is unique because it is currently the world’s largest cord blood bank, with over a half million cord blood and cord tissue units in storage. This is substantially more than its nearest competitor, ViaCord, which has 350,000 units stored. It was acquired by pharmaceutical giant, AMAG Pharmaceuticals, for $700 million in June 2015.
The company’s mission is “to support the advancement of newborn stem cell research, with the hope that the investment you are making now will be valuable to your family in the future.” They provide a high-quality system for the preservation of stem cells and its long-term storage. They created this system to protect the resources that can be beneficial to future medical uses of families who banked in them.
Viacord stands out in the marketplace because it became a part of PerkinElmer, a global company with $2.2 billion dollars in annual revenue, since October of 2006. Currently, ViaCord has released the most cord blood units for medical transplant and has the highest survival rate for cord blood transplant among companies that have shared complete transplant data.
The one-year survival rate for patients who were treated with the company’s cord blood units is 88%, and the long-term patient survival rate is 82%.1
The company’s approach is simple. They apply advanced science to provide their customers a high-quality collection of stem cells and storage procedure. Aside from umbilical cord tissue and cord blood banking, they also offer genomic testing, a diagnostic DNA testing to determine any health issues or disorders before symptoms appear. This procedure also helps families make better decisions in dealing with life-threatening diseases.
In 1989, Cryo-Cell International was founded in Oldsmar, FL, making it the oldest cord blood bank in the world. In 1992, it began to store cord blood. In addition to pursuing a wide variety of accreditations (AABB, cGMP, and ISO 1345), it was the first private cord blood bank in the U.S. to be awarded FACT accreditation.
In 2017, it initiated a $100,000 Engraftment Guarantee (previously $75,000), the highest quality guarantee of any U.S. cord blood bank. It is the only private bank in the U.S. to offer the PrepaCyte-CB cord blood banking technology, a system that leads the industry in engraftment times.
The company also offers two processing methods to their clients: the premium industry and standard, which they promise clients a return on investment. They don’t require an enrollment fee as well unless the child is born and the cord blood and cord tissue have been stored and processed. Cryo-Cell gives a referral reward of one-year free storage to existing customers who have friends or family members who will bank in them.
Part of the reason for the dominance of these three companies in terms of the total number of units stored is that they are three of the oldest cord blood banks within the U.S., founded in 1992, 1993, and 1989, respectively. All three of these cord blood banks also support cord blood research and clinical trials, which play an important role in the success of stem cell treatment in regenerative medicine.
These companies have also been successful with their stem cell campaign and are constantly getting bigger. A comparative analysis of services and features is shown below for these top 3 U.S. market leaders.
Next, a comparative analysis of pricing is shown below for these U.S. cord blood banking market.
One common thing among the top 3 cord blood banks is that they were established more than a decade ago and have continuously grown bigger over the years. It’s not surprising they are some of the largest blood banks in the world, as they have constantly evolved in terms of technology and services.
Whichever one you choose, we hope you find the best cord blood bank for your individual needs.
If you found this blog valuable, subscribe to BioInformant’s stem cell industry updates.
Bordeaux, France – November, 17th, 2020 —The French Blood Agency (EFS) and TreeFrog Therapeutics announce a partnership to advance the mass-production of iPSC-derived HSC transplants based on a patented differentiation protocol developed by the EFS (UMR S938), the Institute for Radioprotection and Nuclear Safety (IRSN) and Sorbonne University[1]. [Read more…]
